In agreement, the meta-analysis of 33 TCGA-provided cancer transcriptome data sets, including 9282 tumor samples, indicated that high IGF2BP1 expression is associated with reduced overall survival probability (Figure 1A). Here, IGF2BP1 is linked to neoplasm.